T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis

被引:655
作者
Facciabene, Andrea [1 ]
Motz, Gregory T. [1 ]
Coukos, George [1 ]
机构
[1] Univ Penn, Ovarian Canc Res Ctr, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
CHRONIC LYMPHOCYTIC-LEUKEMIA; LOW-DOSE CYCLOPHOSPHAMIDE; COLON-CANCER PATIENTS; STAGE OVARIAN-CANCER; PHASE-I TRIAL; METASTATIC MELANOMA; ANTITUMOR IMMUNITY; TGF-BETA; MEDIATED SUPPRESSION; MONOCLONAL-ANTIBODY;
D O I
10.1158/0008-5472.CAN-11-3687
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
T-regulatory cells (Tregs) are found infiltrating tumors in a vast array of tumor types, and tumor-infiltrating Tregs are often associated with a poor clinical outcome. Tregs are potent immunosuppressive cells of the immune system that promote progression of cancer through their ability to limit antitumor immunity and promote angiogenesis. Here, we discuss the ways in which Tregs suppress the antitumor immune response and elaborate on our recent discovery that Tregs make significant direct contributions to tumor angiogenesis. Further, we highlight several current therapies aimed at eliminating Tregs in cancer patients. Given the multifaceted role of Tregs in cancer, a greater understanding of their functions will ultimately strengthen future therapies. Cancer Res; 72(9); 2162-71. (C) 2012 AACR.
引用
收藏
页码:2162 / 2171
页数:10
相关论文
共 112 条
[1]   CD8+T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells [J].
Antony, PA ;
Piccirillo, CA ;
Akpinarli, A ;
Finkelstein, SE ;
Speiss, PJ ;
Surman, DR ;
Palmer, DC ;
Chan, CC ;
Klebanoff, CA ;
Overwijk, WW ;
Rosenberg, SA ;
Restifo, NP .
JOURNAL OF IMMUNOLOGY, 2005, 174 (05) :2591-2601
[2]   Selective elimination of human regulatory T lymphocytes in vitro with the recombinant immunotoxin LMB-2 [J].
Attia, P ;
Powell, DJ ;
Maker, AV ;
Kreitman, RJ ;
Pastan, I ;
Rosenberg, SA .
JOURNAL OF IMMUNOTHERAPY, 2006, 29 (02) :208-214
[3]   Autoimmunity correlates with tumor regression in patients with metastatic melanoma treated with anti-cytotoxic T-lymphocyte antigen-4 [J].
Attia, P ;
Phan, GQ ;
Maker, AV ;
Robinson, MR ;
Quezado, MM ;
Yang, JC ;
Sherry, RM ;
Topalian, SL ;
Kammula, US ;
Royal, RE ;
Restifo, NP ;
Haworth, LR ;
Levy, C ;
Mavroukakis, SA ;
Nichol, G ;
Yellin, MJ ;
Rosenberg, SA .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (25) :6043-6053
[4]   Inability of a fusion protein of IL-2 and diphtheria toxin (Denileukin Diftitox, DAB389IL-2, ONTAK) to eliminate regulatory T lymphocytes in patients with melanoma [J].
Attia, P ;
Maker, AV ;
Haworth, LR ;
Rogers-Freezer, L ;
Rosenberg, SA .
JOURNAL OF IMMUNOTHERAPY, 2005, 28 (06) :582-592
[5]   Timeline - The evolution of thalidomide and its IMiD derivatives as anticancer agents [J].
Bartlett, JB ;
Dredge, K ;
Dalgleish, AG .
NATURE REVIEWS CANCER, 2004, 4 (04) :314-322
[6]   Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse [J].
Bates, Gaynor J. ;
Fox, Stephen B. ;
Han, Cheng ;
Leek, Russell D. ;
Garcia, Jose F. ;
Harris, Adrian L. ;
Banham, Alison H. .
JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (34) :5373-5380
[7]   Hypoxia controls CD4+CD25+ regulatory T-cell homeostasis via hypoxia-inducible factor-1α [J].
Ben-Shoshan, Jeremy ;
Maysel-Auslender, Sophia ;
Mor, Adi ;
Keren, Gad ;
George, Jacob .
EUROPEAN JOURNAL OF IMMUNOLOGY, 2008, 38 (09) :2412-2418
[8]   Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial [J].
Benamouzig, Robert ;
Uzzan, Bernard ;
Deyra, Jacques ;
Martin, Antoine ;
Girard, Bernard ;
Little, Julian ;
Chaussade, Stanislas .
GUT, 2012, 61 (02) :255-261
[9]   Reduced frequencies and suppressive function of CD4+CD25hi regulatory T cells in patients with chronic lymphocytic leukemia after therapy with fludarabine [J].
Beyer, M ;
Kochanek, M ;
Darabi, K ;
Popov, A ;
Jensen, M ;
Endl, E ;
Knolle, PA ;
Thomas, RK ;
von Bergwelt-Baildon, M ;
Bebey, S ;
Hallek, M ;
Schultze, JL .
BLOOD, 2005, 106 (06) :2018-2025
[10]   Cyclic adenosine monophosphate is a key component of regulatory T cell mediated suppression [J].
Bopp, Tobias ;
Becker, Christian ;
Klein, Matthias ;
Klein-Hessling, Stefan ;
Palmetshofer, Alois ;
Serfling, Edgar ;
Heib, Valeska ;
Becker, Marc ;
Kubach, Jan ;
Schmitt, Steffen ;
Stoll, Sabine ;
Schild, Hansjoerg ;
Staege, Martin S. ;
Stassen, Michael ;
Jonuleit, Helmut ;
Schmitt, Edgar .
JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (06) :1303-1310